Open Scanner

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Applied Therapeutics Inc

APLT
Current price
2.5 USD +0.08 USD (+3.31%)
Last closed 2.42 USD
Sector Healthcare
Industry Biotechnology
Exchange NASDAQ
Capitalization 186 894 672 USD
Yield for 12 month +177.62 %
Week
Month
Year
APLT
21.11.2021 - 28.11.2021

Applied Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops novel products to target central nervous system rare disease and diabetic complications in the United States. Its lead product candidate is AT-007 that has completed phase III for the treatment of galactosemia in healthy volunteers and adults, as well as is in pediatric clinical study for the treatment of galactosemia in kids; for treating sorbitol dehydrogenase deficiency; and for the treatment of phosphomannomutase enzyme-CDG. The company also develops AT-001 that is in phase III clinical trials to treat diabetic cardiomyopathy, as well as for the treatment of diabetic peripheral neuropathy; and AT-003, which is in preclinical studies for the treatment diabetic retinopathy. Applied Therapeutics, Inc. was incorporated in 2016 and is headquartered in New York, New York. Address: 545 Fifth Avenue, New York, NY, United States, 10017

Analytics

WallStreet Target Price

7.67 USD

P/E ratio

Dividend Yield

Current Year

Last Year

Current Quarter

Last Quarter

Current Year

Last Year

Current Quarter

Last Quarter

Key Figures APLT

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA -62 497 000 USD
Operating Margin TTM -586.3 %
PE Ratio
Return On Assets TTM -76.69 %
PEG Ratio
Return On Equity TTM -682.16 %
Wall Street Target Price 7.67 USD
Revenue TTM 10 660 000 USD
Book Value -0.14 USD
Revenue Per Share TTM 0.15 USD
Dividend Share
Quarterly Revenue Growth YOY
Dividend Yield
Gross Profit TTM
Earnings Share -1.25 USD
Diluted Eps TTM -1.25 USD
Most Recent Quarter III 2023
Quarterly Earnings Growth YOY
Profit Margin

Dividend Analytics APLT

Dividend growth over 5 years

Continuous growth

Payout Ratio 5 years average

Dividend History APLT

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date
Forward Annual Dividend Yield
Last Split Factor
Payout Ratio
Last Split Date
Dividend Date

Stock Valuation APLT

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE
Enterprise Value Revenue 14.1414
Price Sales TTM 17.5323
Enterprise Value EBITDA -2.43
Price Book MRQ 4.8902

Financials APLT

1 year
3 years
5 years
10 years
Results 2019 Dynamics

Technical indicators APLT

For 52 weeks

0.7 USD 3.11 USD
50 Day MA 2.32 USD
Shares Short Prior Month 1 925 645
200 Day MA 1.58 USD
Short Ratio 3.06
Shares Short 1 979 892
Short Percent 3.05 %